Ketamine for the treatment of addiction: Evidence and potential mechanisms
- PMID: 29339294
- DOI: 10.1016/j.neuropharm.2018.01.017
Ketamine for the treatment of addiction: Evidence and potential mechanisms
Abstract
Ketamine is a dissociative anaesthetic drug which acts on the central nervous system chiefly through antagonism of the n-methyl-d-aspartate (NMDA) receptor. Recently, ketamine has attracted attention as a rapid-acting anti-depressant but other studies have also reported its efficacy in reducing problematic alcohol and drug use. This review explores the preclinical and clinical research into ketamine's ability to treat addiction. Despite methodological limitations and the relative infancy of the field, results thus far are promising. Ketamine has been shown to effectively prolong abstinence from alcohol and heroin in detoxified alcoholics and heroin dependent individuals, respectively. Moreover, ketamine reduced craving for and self-administration of cocaine in non-treatment seeking cocaine users. However, further randomised controlled trials are urgently needed to confirm ketamine's efficacy. Possible mechanisms by which ketamine may work within addiction include: enhancement of neuroplasticity and neurogenesis, disruption of relevant functional neural networks, treating depressive symptoms, blocking reconsolidation of drug-related memories, provoking mystical experiences and enhancing psychological therapy efficacy. Identifying the mechanisms by which ketamine exerts its therapeutic effects in addiction, from the many possible candidates, is crucial for advancing this treatment and may have broader implications understanding other psychedelic therapies. In conclusion, ketamine shows great promise as a treatment for various addictions, but well-controlled research is urgently needed. This article is part of the Special Issue entitled 'Psychedelics: New Doors, Altered Perceptions'.
Keywords: Addiction treatment; Alcohol use disorder; Ketamine; Neurogenesis; Psychedelic therapy.
Copyright © 2018. Published by Elsevier Ltd.
Similar articles
-
Mystical-type experiences occasioned by ketamine mediate its impact on at-risk drinking: Results from a randomized, controlled trial.J Psychopharmacol. 2021 Feb;35(2):150-158. doi: 10.1177/0269881120970879. Epub 2020 Dec 13. J Psychopharmacol. 2021. PMID: 33307947 Clinical Trial.
-
Overlap in the neural circuitry and molecular mechanisms underlying ketamine abuse and its use as an antidepressant.Behav Brain Res. 2020 Apr 20;384:112548. doi: 10.1016/j.bbr.2020.112548. Epub 2020 Feb 13. Behav Brain Res. 2020. PMID: 32061748 Free PMC article. Review.
-
A sub-set of psychoactive effects may be critical to the behavioral impact of ketamine on cocaine use disorder: Results from a randomized, controlled laboratory study.Neuropharmacology. 2018 Nov;142:270-276. doi: 10.1016/j.neuropharm.2018.01.005. Epub 2018 Jan 5. Neuropharmacology. 2018. PMID: 29309770 Free PMC article. Clinical Trial.
-
Psychedelics and reconsolidation of traumatic and appetitive maladaptive memories: focus on cannabinoids and ketamine.Psychopharmacology (Berl). 2018 Feb;235(2):433-445. doi: 10.1007/s00213-017-4793-4. Epub 2017 Nov 25. Psychopharmacology (Berl). 2018. PMID: 29178010 Review.
-
A unified model of ketamine's dissociative and psychedelic properties.J Psychopharmacol. 2023 Jan;37(1):14-32. doi: 10.1177/02698811221140011. Epub 2022 Dec 17. J Psychopharmacol. 2023. PMID: 36527355 Free PMC article. Review.
Cited by
-
Ketamine in Substance Use Disorder Treatment: A Narrative Review.Alpha Psychiatry. 2024 Mar 1;25(2):206-211. doi: 10.5152/alphapsychiatry.2024.241522. eCollection 2024 Mar. Alpha Psychiatry. 2024. PMID: 38798813 Free PMC article. Review.
-
Implications of Kynurenine Pathway Metabolism for the Immune System, Hypothalamic-Pituitary-Adrenal Axis, and Neurotransmission in Alcohol Use Disorder.Int J Mol Sci. 2024 Apr 29;25(9):4845. doi: 10.3390/ijms25094845. Int J Mol Sci. 2024. PMID: 38732064 Free PMC article. Review.
-
Attenuation of intestinal ischemia-reperfusion-injury by anesthetics: a potentially protective effect of anesthetic management in experimental studies.Front Pharmacol. 2024 Feb 20;15:1367170. doi: 10.3389/fphar.2024.1367170. eCollection 2024. Front Pharmacol. 2024. PMID: 38444936 Free PMC article. Review.
-
Role of Flt3l and Rps15 in ketamine anesthesia.Medicine (Baltimore). 2024 Mar 1;103(9):e37123. doi: 10.1097/MD.0000000000037123. Medicine (Baltimore). 2024. PMID: 38428846 Free PMC article.
-
Ketamine, an Old-New Drug: Uses and Abuses.Pharmaceuticals (Basel). 2023 Dec 21;17(1):16. doi: 10.3390/ph17010016. Pharmaceuticals (Basel). 2023. PMID: 38276001 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical